The World Health Organization (WHO) announced this week that it has elected to declare the Ebola outbreak in the Democratic Republic of Congo a “public health emergency of international concern,” a decision that comes nearly a year after the outbreak was first declared and after the infection of thousands of people. Continue reading Ebola Outbreak Declared a Public Health Emergency by World Health Organization
LAST MONTH THE Food and Drug Administration sent out an emergency alert: Two people who had undergone fecal transplants developed multi-drug-resistant infections from bacteria in the stool they were given, and one died. Continue reading THE DEATH OF A PATIENT AND THE FUTURE OF FECAL TRANSPLANTS
A federal investigation reveals unsettling details about the country’s food supply. Continue reading The FDA Finds High Levels of Toxic Compound in Commons Foods
The Centers for Disease Control and Prevention on Thursday said that measles cases hit a higher number this year than has been reported since 1994. If the outbreaks continue as they are, the health agency says it could cost the U.S. its elimination status. Continue reading Measles Cases in 2019 Have Hit a 25-Year High Amid Ongoing Outbreaks, CDC Says
Developing an H.I.V. vaccine has been a perplexing challenge that has mostly resulted in failure, but now scientists have identified key factors that allow some people to naturally suppress the H.I.V. virus—work that could lead to better vaccines to both treat and prevent the infection. Researchers believe they have identified crucial points on the virus’s surface where the immune system can successfully attack H.I.V.
Cannabidiol, or CBD, is one of the main compounds of marijuana and its use is one of the most popular trends in the health and wellness scene thanks to its numerous health benefits. Continue reading CBD 101: EVERYTHING YOU NEED TO KNOW ABOUT THE HOTTEST TREND IN CANNABIS
The first U.S. trial of CRISPR in humans has begun, NPR reported Tuesday. Two patients are currently being treated as part of a University of Pennsylvania study. Per NPR, both have difficult-to-treat forms of cancer and both have relapsed after regular treatments. As part of the trial, researchers are taking immune cells from the patients’ own bodies and editing them with CRISPR before putting them back in. The hope is that these edited cells will be better at identifying and attacking the cancer than their unaltered counterparts. According to the U.S. government clinical trial registry, the researchers are hoping to enroll 18 people in their study. But it’s not certain yet whether they’ll be approved for that many subjects, reports Jon Fingas for Engadget. Continue reading CRISPR is now being used on humans in the U.S.